Minimally Invasive Therapies for Early Stage Non-small Cell Lung Cancer.
10.3779/j.issn.1009-3419.2020.101.01
- Author:
Tianyu HE
1
;
Jinlin CAO
1
;
Jinming XU
1
;
Wang LV
1
;
Jian HU
1
Author Information
1. Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China.
- Publication Type:Journal Article
- Keywords:
Interventional treatment;
Lung neoplasms;
Minimally invasive treatment
- From:
Chinese Journal of Lung Cancer
2020;23(6):479-486
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the most common cancer and the leading cause of cancer death in the world, among which non-small cell lung cancer (NSCLC) accounts for about 85% of the total lung cancer. With the widespread of computed tomography (CT) and other imaging screening methods, the pathological types of lung cancer have changed from central squamous cell carcinoma to the early-stage lung adenocarcinoma, which is manifested as isolated pulmonary nodules and ground glass nodules on CT. Early diagnosis and treatment of lung cancer is of crucial clinical significance, and the continuous development and improvement of minimally invasive interventional techniques provide more options for lung cancer treatment, such as stereotactic radiation, percutaneous ablation, and bronchial intervention. This paper will make a review on the principle, advantages, disadvantages and prospects of minimally invasive interventional therapy commonly used in clinical practice.
